(To see other currencies, click on price)
MORE ABOUT THIS BOOK
Main description:
Te rapidly changing concepts in radiation oncology with the development of more precise - strumentation for delivery of radiation therapy and a greater emphasis on hypofractionation technologies require a very intimate knowledge of tumor biology and the infuence of various biologic factors on dose distribution within the tumor in terms of homogeneity as well as prev- tion of any late efects on normal tissue surrounding the tumor itself. Not only are these major factors in clinical practice but also the known factors of inhomogeneity of cancer cells, the impact of microenvironment in terms of radiation efect, and host factors make it mandatory to design therapeutic strategies to improve the outcome and to diminish any potential short-term or lo- term risks from the radiation therapy. Te authors have developed an outstanding text that deals with these strategies and how they would impact on established and emerging new technologies and treatment. Te context of the presentations within a multidisciplinary combined modality therapy program is incredibly - portant. In this volume, various topics are reviewed including tumor genesis, cell proliferation, - giogenesis, the physiologic characteristics of malignant tissues, invasion and adhesion, the route and role pursued in the development of metastasis, and the role of the human immune system in cancer prevention and development.
Contents:
Tumorigenesis.- Tumor Growth and Cell Proliferation.- Angiogenesis.- Tumor Physiology (Phenomenology).- Adhesion, Invasion, Integrins and Beyond.- Development of Metastases.- Role of the Immune System in Cancer Development and Therapeutic Implications.- Cancer Prevention .- Tumor Detection by Morphological and Biological Imaging.- Tumor Detection by Biological Markers (Serum, Urine, Breathing Gas, Proteomics).- Quantitative Cell Kill by Chemo- and Radiotherapy.- Impact of Molecularly Targeted Agents on Cell Kill in Bi- or Trimodal Approaches (i.e. plus Chemo, Radio-, or Radiochemotherapy).- Translational Studies for Target-Based Drugs.- Molecular Mechanisms of Treatment Resistance.- Physiological Mechanisms of Treatment Resistance.- Influence of Repopulation on Treatment Resistance.- Molecular Tools, Gene Expression Profiling.- Strategies of Gene Transfer/Silencing and Technical Considerations.- Tumor Biology's Impact on Clinical Cure Rates.- Can Dose-Escalated Radiotherapy Eventually Cure All Biologically Distinct Subsets of a Certain Tumor Type? Answers from Stereotactic Lung and Liver Radiotherapy Experience.-Low-Dose Radiotherapy - A Chemopotentiator?.- Treatment of the Primary Tumor in Metastatic Cancer: Influence on Outcome.- Subject Index.- List of Contributors.
Publisher recommends
From the same series
Victor N. Cassar-Pullicino
Johny A. Verschakelen
Johan G. Blickman
Luther W. Brady
Hans-Ulrich Kauczor
Elke Hattingen
Stefan Hahnel
William Small
Giuseppe Guglielmi
Christoph Stippich
Daniela Prayer
Lotfi Hendaoui
Hans Geinitz
Mark G. Cowling
Marc Lemmerling
A.L. Baert
Richard P. Baum
Pilar Garcia-Peña
Emilio Quaia
Dr John Reidy
H.-P. Heilmann
Charles R. Thomas JR
Carsten Nieder
Carsten Nieder
Maximilian F. Reiser
Henrik S. Thomsen
Balazs Ruzsics
Marc-Andre Weber
John T. Hansen
John T. Hansen
John T. Hansen
Giovanni Maconi
Albert L. Baert
Emanuele Neri
Stefan Hahnel
Giuseppe Guglielmi
Horst Urbach
A. Mark Davies
A.L. Baert
Georges Y. El-Khoury
Andrea Baur-Melnyk
Francis Joffre
Anthony H. Chapman
Ali Guermazi
W.E. Alberti
A.L. Baert
Volkmar Nicolas
A.L. Baert
A.L. Baert
A.L. Baert
Fred E. Avni
Kie Kian Ang
A.L. Baert
H.-P. Heilmann
H.-P. Heilmann
A.L. Baert
Olle Ekberg
Jiade J. Lu
Thomas Kahn
Ali Guermazi
Hans-Ulrich Kauczor
Peter R. Mueller
Mannudeep K. Kalra
Jiade J. Lu
D.-M. Koh
H.-P. Heilmann
H.-P. Heilmann
W. Richard Webb
Erich K. Lang
F. Heuck
Mariano Scaglione
Luther W. Brady
Charles W. Scarantino
Friedrich Heuck
Vivek Muthurangu
A.L. Baert
Luther W. Brady
A.L. Baert
H.-P. Heilmann
Luther W. Brady
Heinrich Iro
H.-P. Heilmann
Luther W. Brady
Robert Hermans
H.-P. Heilmann
Albert L. Baert
H.-P. Heilmann
Erich K. Lang
H.-P. Heilmann
Luther W. Brady
H.-P. Heilmann
H.-P. Heilmann
H.-P. Heilmann
Alec J. Megibow
Carlos A. Perez
Lotfi Hendaoui
Michele Bertolotto
Goetz Benndorf
A. Mark Davies
Sylvia H. Heywang-Kobrunner
Jurgen Hennig
A.L. Baert
A.L. Baert
A.L. Baert
A.L. Baert
Branislav Jeremic
Luther W. Brady
Patrice Taourel
Caroline Keyzer
Luther W. Brady
A.L. Baert
A. Mark Davies
Erich K. Lang
Paul R. Algra
Jaap Stoker
Albert L. Baert
Albert L. Baert
H.-P. Heilmann
H.-P. Heilmann
Luther W. Brady
Carsten Nieder
Apostolos H. Karantanas
Daniela Prayer
Michael Molls
Luther W. Brady
A.L. Baert
A.L. Baert
Luther W. Brady
A.L. Baert
Luther W. Brady
Luther W. Brady
Albert L. Baert
A.L. Baert
Alexander A. Bankier
Emmanuel E. Coche
Jaap Stoker
Luther W. Brady
David J. Wilson
A.L. Baert
Alec J. Megibow
Michael Forsting
Martine Remy-Jardin
Albert L. Baert
Maximilian F. Reiser
Christoph Stippich
Christoph R. Becker
Bernd Hamm
A.L. Baert
J. Martin Brown
Thomas J. Vogl
A.L. Baert
A.L. Baert
D.-M. Koh
Ulrich Bick
Albert L. Baert
Luther W. Brady
Jaap Stoker
Murali Sundaram
Alec J. Megibow
Georges Y. El-Khoury
A.L. Baert
Christoph R. Becker
Luther W. Brady
Luther W. Brady
Luther W. Brady
A.L. Baert
A.L. Baert
Thomas J. Vogl
A.L. Baert
A.L. Baert
A.L. Baert
Luther W. Brady
A.L. Baert
Alexander A. Bankier
Bernd Hamm
A.L. Baert
A.L. Baert
J. Martin Brown
Jafar Golzarian
A.L. Baert